Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.44 |
| ▸ | CETP | P11597 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.37 |
| ▸ | ACACA | Q13085 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
| ▸ | RELA | Q04206 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CRHBP | P24387 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL118655 | 1.00 | FFAR1 (0.44) | FFAR1CETPALDH1A1LTA4HPPARG | |
| SCHEMBL9862593 | 1.00 | FFAR1 (0.44) | FFAR1CETPALDH1A1LTA4HPPARG | |
| SCHEMBL409247 | 0.92 | FFAR1 (0.51) | FFAR1CETPLTA4HACACBACACA | |
| SCHEMBL9561406 | 0.92 | FFAR1 (0.51) | FFAR1CETPLTA4HACACBACACA | |
| SCHEMBL9560890 | 0.92 | CETP (0.44) | FFAR1CETPALDH1A1PPARGPPARA | |
| SCHEMBL9570568 | 0.90 | FFAR1 (0.44) | FFAR1CETPALDH1A1LTA4HACACB | |
| SCHEMBL9570819 | 0.90 | FFAR1 (0.44) | FFAR1CETPALDH1A1LTA4HACACB | |
| SCHEMBL9570818 | 0.90 | FFAR1 (0.44) | FFAR1CETPLTA4HACACBACACA | |
| SCHEMBL9560487 | 0.90 | PPARG (0.47) | FFAR1CETPALDH1A1PPARGPPARA | |
| SCHEMBL409736 | 0.89 | FFAR1 (0.44) | FFAR1CETPALDH1A1LTA4HACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025244856-A1 | METHODS AND COMPOSITIONS RELATING TO ELQ COMPOUNDS | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2025-11-27 | — | — | WO | claimed |
| US-12589037-B2 | Wearable article comprising a laminate | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-31 | — | — | US | disclosed |
| US-12485045-B2 | Wearable article comprising an elastic laminate | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-02 | — | — | US | disclosed |
| WO-2025244856-A1 | METHODS AND COMPOSITIONS RELATING TO ELQ COMPOUNDS | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2025-11-27 | — | — | WO | disclosed |
| US-20250281926-A1 | SAMPLE MANIPULATION AND ASSAY WITH RAPID TEMPERATURE CHANGE | ESSENLIX CORPORATION (US) | 2025-09-11 | — | — | US | disclosed |
| CN-115802991-B | Wearable article including elastic laminate | 宝洁公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20250177360-A1 | METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE | CARTESIAN THERAPEUTICS, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| US-12318271-B2 | Wearable article comprising an elastic laminate having good wicking properties | THE PROCTER & GAMBLE COMPANY (US) | 2025-06-03 | — | — | US | disclosed |
| US-12274606-B2 | Wearable article comprising an elastic belt laminate | THE PROCTER & GAMBLE COMPANY (US) | 2025-04-15 | — | — | US | disclosed |
| US-12270810-B2 | QMAX assay and applications (II) | ESSENLIX CORPORATION (US) | 2025-04-08 | — | — | US | disclosed |
| US-20220079817-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC LAMINATE HAVING GOOD WICKING PROPERTIES | THE PROCTER & GAMBLE COMPANY | 2022-03-17 | — | — | US | disclosed |
| US-11274996-B2 | Compressed open flow assay and use | ESSENLIX CORPORATION (US) | 2022-03-15 | — | — | US | disclosed |
| US-20220071816-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC BELT LAMINATE HAVING HYDROPHILIC INNER AND OUTER WEB | THE PROCTER & GAMBLE COMPANY | 2022-03-10 | — | — | US | disclosed |
| US-20220071814-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC BELT LAMINATE | THE PROCTER & GAMBLE COMPANY | 2022-03-10 | — | — | US | disclosed |
| US-20220071813-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC LAMINATE | THE PROCTER & GAMBLE COMPANY | 2022-03-10 | — | — | US | disclosed |
| WO-2022022424-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC LAMINATE | THE PROCTER & GAMBLE COMPANY (US) | 2022-02-03 | — | — | WO | disclosed |
| WO-2022021266-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC LAMINATE | THE PROCTER & GAMBLE COMPANY (US) | 2022-02-03 | — | — | WO | disclosed |
| WO-2022021295-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC LAMINATE HAVING GOOD WICKING PROPERTIES | THE PROCTER & GAMBLE COMPANY (US) | 2022-02-03 | — | — | WO | disclosed |
| WO-2022021294-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC LAMINATE | THE PROCTER & GAMBLE COMPANY (US) | 2022-02-03 | — | — | WO | disclosed |
| WO-2022021265-A1 | WEARABLE ARTICLE COMPRISING AN ELASTIC BELT LAMINATE HAVING HYDROPHILIC INNER AND OUTER WEB | THE PROCTER & GAMBLE COMPANY (US) | 2022-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177360-A1 | METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE | SERPINA6, FCGRT, FCGR3B | FFAR1 4578/4885CETP 426/4885ALDH1A1 3603/4885 |
| US-12589037-B2 | Wearable article comprising a laminate | CUTA, DSP, FSCN1 | FFAR1 2104/4885CETP 1892/4885ALDH1A1 1585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.